[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100468825":3},{"organization":4,"armGroups":7,"interventions":18,"overallOfficials":41,"centralContacts":48,"locations":56,"responsibleParty":334,"collaborators":24,"id":336,"slug":337,"hasResults":338,"nctId":339,"briefTitle":340,"officialTitle":341,"acronym":342,"eligibilityCriteria":343,"healthyVolunteers":338,"sex":344,"minAge":345,"maxAge":346,"enrollmentInfo":347,"targetDuration":24,"studyType":350,"phases":351,"briefSummary":354,"conditions":355,"keywords":357,"overallStatus":78,"whyStopped":24,"lastUpdateSubmitDate":361,"lastUpdatePostDateStruct":362,"startDateStruct":365,"completionDateStruct":367,"leadSponsor":369,"locationsCount":370},{"fullName":5,"class":6},"Centre Oscar Lambret","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Single Arm - Vincristine + Irinotécan + Témozolomide + Etoposide + Cis-Retinoic acid","EXPERIMENTAL","Metronomic chemotherapy : Vincristine + Irinotécan + Témozolomide + Etoposide + Cis-Retinoic acid",[13,14,15,16,17],"Drug: Vincristine","Drug: Irinotecan","Drug: Temozolomide","Drug: Etoposide","Drug: Cis-Retinoic acid",[19,25,29,33,37],{"type":20,"name":21,"description":22,"armGroupLabels":23,"otherNames":24},"DRUG","Vincristine","IV, D1-D22-D43 and D64",[9],null,{"type":20,"name":26,"description":27,"armGroupLabels":28,"otherNames":24},"Irinotecan","Oral, 5 days\u002Fweek during W1,W2,W7 and W8 (D1 to D5, D8 to D12, D43 to D47, D50 to D54)",[9],{"type":20,"name":30,"description":31,"armGroupLabels":32,"otherNames":24},"Temozolomide","Oral,3 weeks in a row, twice per cycle (D1 to D21, D43 to D63)",[9],{"type":20,"name":34,"description":35,"armGroupLabels":36,"otherNames":24},"Etoposide","Oral, 3 weeks in a row, twice per cycle (D22 to D42, D64 to D84)",[9],{"type":20,"name":38,"description":39,"armGroupLabels":40,"otherNames":24},"Cis-Retinoic acid","Oral, 2 weeks in a row, thrice per cycle (D15 to D28, D43 to D56, D71 to D84)",[9],[42,45],{"name":43,"affiliation":5,"role":44},"Hélène SUDOUR-BONNANGE, MD","PRINCIPAL_INVESTIGATOR",{"name":46,"affiliation":47,"role":44},"Arnauld VERSCHUUR, MD, PhD","CHU La Timone",[49,54],{"name":50,"role":51,"phone":52,"phoneExt":24,"email":53},"Emilie Heyman - Decoupigny","CONTACT","+33 (0)3 20 29 59 18","promotion@o-lambret.fr",{"name":55,"role":51,"phone":52,"phoneExt":24,"email":53},"Marie Vanseymortier",[57,76,91,106,121,138,153,169,184,199,214,229,244,259,274,289,304,319],{"facility":58,"status":59,"city":60,"state":24,"zip":61,"country":62,"countryCode":63,"cosmosGeoPoint":64,"geoPoint":69,"contacts":70},"CHU Amiens Picardie","NOT_YET_RECRUITING","Amiens","80054","France","FR",{"type":65,"coordinates":66},"Point",[67,68],2.3,49.9,{"lat":68,"lon":67},[71,75],{"name":72,"role":51,"phone":73,"phoneExt":24,"email":74},"Leslie ANDRY, MD","+33 3 22 08 76 44","andry.leslie@chu-amiens.fr",{"name":72,"role":44,"phone":24,"phoneExt":24,"email":24},{"facility":77,"status":78,"city":79,"state":24,"zip":24,"country":62,"countryCode":63,"cosmosGeoPoint":80,"geoPoint":84,"contacts":85},"CHU de Besancon","RECRUITING","Besançon",{"type":65,"coordinates":81},[82,83],6.01815,47.24878,{"lat":83,"lon":82},[86,90],{"name":87,"role":51,"phone":88,"phoneExt":24,"email":89},"Véronique LAITHIER, MD","0381219182","vlaithier@chu-besancon.fr",{"name":87,"role":44,"phone":24,"phoneExt":24,"email":24},{"facility":92,"status":78,"city":93,"state":24,"zip":94,"country":62,"countryCode":63,"cosmosGeoPoint":95,"geoPoint":99,"contacts":100},"CHRU de Bordeaux Hôpital des Enfants","Bordeaux","33076",{"type":65,"coordinates":96},[97,98],-0.58046,44.84124,{"lat":98,"lon":97},[101,105],{"name":102,"role":51,"phone":103,"phoneExt":24,"email":104},"Anne NOTZ- CARRERE, MD","+33 5 57 82 04 34","anne.notz-carrere@chu-bordeaux.fr",{"name":102,"role":44,"phone":24,"phoneExt":24,"email":24},{"facility":107,"status":78,"city":108,"state":24,"zip":109,"country":62,"countryCode":63,"cosmosGeoPoint":110,"geoPoint":114,"contacts":115},"CHU GRENOBLE ALPES - Hôpital COUPLE ENFANT","Grenoble","38043",{"type":65,"coordinates":111},[112,113],5.71479,45.17869,{"lat":113,"lon":112},[116,120],{"name":117,"role":51,"phone":118,"phoneExt":24,"email":119},"Dominique PLANTAZ, MD","+33 4 76 76 59 11","DPlantaz@chu-grenoble.fr",{"name":117,"role":44,"phone":24,"phoneExt":24,"email":24},{"facility":5,"status":78,"city":122,"state":24,"zip":123,"country":62,"countryCode":63,"cosmosGeoPoint":124,"geoPoint":128,"contacts":129},"Lille","59020",{"type":65,"coordinates":125},[126,127],3.05512,50.63391,{"lat":127,"lon":126},[130,133,136,137],{"name":43,"role":51,"phone":131,"phoneExt":24,"email":132},"+33 3 20 29 59 56","h-sudour@o-lambret.fr",{"name":134,"role":51,"phone":131,"phoneExt":24,"email":135},"Cyril LERVAT, MD","c-lervat@o-lambret.fr",{"name":43,"role":44,"phone":24,"phoneExt":24,"email":24},{"name":134,"role":44,"phone":24,"phoneExt":24,"email":24},{"facility":139,"status":78,"city":140,"state":24,"zip":141,"country":62,"countryCode":63,"cosmosGeoPoint":142,"geoPoint":146,"contacts":147},"Centre Léon Bérard","Lyon","69373",{"type":65,"coordinates":143},[144,145],4.84789,45.74906,{"lat":145,"lon":144},[148,152],{"name":149,"role":51,"phone":150,"phoneExt":24,"email":151},"Benoit DUMONT, MD","+33 4 69 16 65 74","Benoit.DUMONT@ihope.fr",{"name":149,"role":44,"phone":24,"phoneExt":24,"email":24},{"facility":154,"status":78,"city":155,"state":24,"zip":156,"country":62,"countryCode":63,"cosmosGeoPoint":157,"geoPoint":161,"contacts":162},"Hôpital pour Enfants \" La Timone \" AP-HM","Marseille","13005",{"type":65,"coordinates":158},[159,160],5.38107,43.29695,{"lat":160,"lon":159},[163,167],{"name":164,"role":51,"phone":165,"phoneExt":24,"email":166},"Arnauld VERSCHUUR, MD","+33 4 91 38 86 21","arnauld.verschuur@ap-hm.fr",{"name":168,"role":44,"phone":24,"phoneExt":24,"email":24},"Arnauld Verschuur, MD",{"facility":170,"status":59,"city":171,"state":24,"zip":172,"country":62,"countryCode":63,"cosmosGeoPoint":173,"geoPoint":177,"contacts":178},"CHU de MONTPELLIER - Hôpital Arnaud de Villeneuve","Montpellier","34295",{"type":65,"coordinates":174},[175,176],3.87635,43.61093,{"lat":176,"lon":175},[179,183],{"name":180,"role":51,"phone":181,"phoneExt":24,"email":182},"Stéphanie HAOUY, MD","+33 4 67 33 65 19","s-haouy@chu-montpellier.fr",{"name":180,"role":44,"phone":24,"phoneExt":24,"email":24},{"facility":185,"status":78,"city":186,"state":24,"zip":187,"country":62,"countryCode":63,"cosmosGeoPoint":188,"geoPoint":192,"contacts":193},"CHU Nantes","Nantes","44093",{"type":65,"coordinates":189},[190,191],-1.55336,47.21725,{"lat":191,"lon":190},[194,198],{"name":195,"role":51,"phone":196,"phoneExt":24,"email":197},"Estelle THEBAUD, MD","+33 2 40 08 36 10","Estelle.THEBAUD@chu-nantes.fr",{"name":195,"role":44,"phone":24,"phoneExt":24,"email":24},{"facility":200,"status":78,"city":201,"state":24,"zip":202,"country":62,"countryCode":63,"cosmosGeoPoint":203,"geoPoint":207,"contacts":208},"CHU de Nice - Hôpital Archet 2","Nice","06202",{"type":65,"coordinates":204},[205,206],7.26608,43.70313,{"lat":206,"lon":205},[209,213],{"name":210,"role":51,"phone":211,"phoneExt":24,"email":212},"Joy BENADIBA, MD","+33 4 92 03 92 68","benadiba.j@chu-nice.fr",{"name":210,"role":44,"phone":24,"phoneExt":24,"email":24},{"facility":215,"status":78,"city":216,"state":24,"zip":217,"country":62,"countryCode":63,"cosmosGeoPoint":218,"geoPoint":222,"contacts":223},"Hôpital Armand-TROUSSEAU","Paris","75012",{"type":65,"coordinates":219},[220,221],2.3488,48.85341,{"lat":221,"lon":220},[224,228],{"name":225,"role":51,"phone":226,"phoneExt":24,"email":227},"Marie Dominique TABONE, MD","+33 1 44 73 68 46","marie-dominique.tabone@aphp.fr",{"name":225,"role":44,"phone":24,"phoneExt":24,"email":24},{"facility":230,"status":78,"city":231,"state":24,"zip":232,"country":62,"countryCode":63,"cosmosGeoPoint":233,"geoPoint":237,"contacts":238},"CHU Hôpital Sud","Rennes","35203",{"type":65,"coordinates":234},[235,236],-1.67431,48.11109,{"lat":236,"lon":235},[239,243],{"name":240,"role":51,"phone":241,"phoneExt":24,"email":242},"Jacinthe BONNEAU-LAGACHERIE, MD","+33 2 99 26 59 17","Jacinthe.BONNEAU-LAGACHERIE@chu-rennes.fr",{"name":240,"role":44,"phone":24,"phoneExt":24,"email":24},{"facility":245,"status":78,"city":246,"state":24,"zip":247,"country":62,"countryCode":63,"cosmosGeoPoint":248,"geoPoint":252,"contacts":253},"Chu Rouen","Rouen","76000",{"type":65,"coordinates":249},[250,251],1.09932,49.44313,{"lat":251,"lon":250},[254,258],{"name":255,"role":51,"phone":256,"phoneExt":24,"email":257},"Aude MARIE-CARDINE, MD","+33 2 32 88 81 91","Aude.Marie-Cardine@chu-rouen.fr",{"name":255,"role":44,"phone":24,"phoneExt":24,"email":24},{"facility":260,"status":59,"city":261,"state":24,"zip":24,"country":62,"countryCode":63,"cosmosGeoPoint":262,"geoPoint":266,"contacts":267},"CHU La Réunion","Saint-Denis",{"type":65,"coordinates":263},[264,265],2.35387,48.93564,{"lat":265,"lon":264},[268,272],{"name":269,"role":51,"phone":270,"phoneExt":24,"email":271},"Yves REGUERRE","0262906110","yves.reguerre@chu-reunion.fr",{"name":273,"role":44,"phone":24,"phoneExt":24,"email":24},"Yves REGUERRE, MD",{"facility":275,"status":78,"city":276,"state":24,"zip":277,"country":62,"countryCode":63,"cosmosGeoPoint":278,"geoPoint":282,"contacts":283},"CHRU Strasbourg - Hôpital de Hautepierre","Strasbourg","67098",{"type":65,"coordinates":279},[280,281],7.74553,48.58392,{"lat":281,"lon":280},[284,288],{"name":285,"role":51,"phone":286,"phoneExt":24,"email":287},"Sarah JANNIER, MD","+33 3 88 12 87 94","sarah.jannier@chru-strasbourg.fr",{"name":285,"role":44,"phone":24,"phoneExt":24,"email":24},{"facility":290,"status":78,"city":291,"state":24,"zip":292,"country":62,"countryCode":63,"cosmosGeoPoint":293,"geoPoint":297,"contacts":298},"CHU Toulouse - Hôpital des Enfants","Toulouse","70034",{"type":65,"coordinates":294},[295,296],1.44367,43.60426,{"lat":296,"lon":295},[299,303],{"name":300,"role":51,"phone":301,"phoneExt":24,"email":302},"Cécile BOULANGER, MD","+33 5 34 55 75 66","boulanger.c@chu-toulouse.fr",{"name":300,"role":44,"phone":24,"phoneExt":24,"email":24},{"facility":305,"status":78,"city":306,"state":24,"zip":307,"country":62,"countryCode":63,"cosmosGeoPoint":308,"geoPoint":312,"contacts":313},"CHRU NANCY - Hôpital d'Enfants","Vandœuvre-lès-Nancy","54500",{"type":65,"coordinates":309},[310,311],6.17114,48.66115,{"lat":311,"lon":310},[314,318],{"name":315,"role":51,"phone":316,"phoneExt":24,"email":317},"Ludovic MANSUY, MD","+33 3 83 15 47 34","lu.mansuy@chru-nancy.fr",{"name":315,"role":44,"phone":24,"phoneExt":24,"email":24},{"facility":320,"status":78,"city":321,"state":24,"zip":322,"country":62,"countryCode":63,"cosmosGeoPoint":323,"geoPoint":327,"contacts":328},"Gustave ROUSSY","Villejuif","94805",{"type":65,"coordinates":324},[325,326],2.35992,48.7939,{"lat":326,"lon":325},[329,333],{"name":330,"role":51,"phone":331,"phoneExt":24,"email":332},"Claudia PASQUALINI, MD","+33 1 42 11 42 11","Claudia.pasqualini@gustaveroussy.fr",{"name":330,"role":44,"phone":24,"phoneExt":24,"email":24},{"type":335,"investigatorFullName":24,"investigatorTitle":24,"investigatorAffiliation":24,"oldNameTitle":24,"oldOrganization":24},"SPONSOR","100468825","phase-1-metronomic-chemotherapy-in-wilms-tumor-metrowilms-1906-100468825",false,"NCT05384821","Metronomic Chemotherapy in Wilms Tumor (MetroWilms-1906)","Phase 1-2 Trial Evaluating Metronomic Chemotherapy in Patients With a Relapsed or Refractory Wilms Tumor","MetroWilms","Inclusion Criteria:\n\n* Patient ≥18 months old and ≤ 17 years old\n* Relapsed or refractory Wilms tumor, histologically proven at diagnosis\n* After at least 2 lines of chemotherapy (conventional or high dose, which may include the trial molecules) or after 1 line for high risk relapse for which there would not be any curative therapy. If 1 line for high risk relapse, the enrolment should be confirmed by coordinators.\n* Radiologically measurable or evaluable disease (visible, target or non-target-lesion on MRI or CT-scan)\n* Performance status: Karnofsky performance status (for patients \\>16 years of age) or Lansky Play score (for patients ≤16 years of age) ≥ 70%.\n* Able to take oral medication or nasal gastric tube or authorized gastrostomy\n* Adequate biological criteria:\n\n  * Neutrophils \\> 1000\u002Fmm3 ; Platelets \\> 75 000\u002Fmm3\n  * Transaminases (ALT\u002F AST) ≤ 3 times ULN (or ≤ 6 times ULN if liver metastasis); total bilirubin ≤ 2 ULN (except in case of Gilbert's disease)\n* Creatinine ≤ 1,5 ULN or clearance ≥ 60 mL\u002F min\u002F 1,73m2 (In case of doubt, to be confirm by assessment of cystatin )\n* Females of childbearing potential must have a negative seric pregnancy test within 7 days prior to initiation of treatment.\n* Sexually active patients must agree to use adequate and appropriate contraception (at least one highly effective contraception or two complementary methods of contraception), 1 month before beginning of treatment while on trial drug and for 7 months after stopping the trial drug for female patients and after 6 months for male patients.\n* Written informed consent from parents\u002Flegal representative, patient, and age-appropriate assent before any trial-specific screening procedures according to national guidelines.\n* Patient covered by the French \"Social Security\" regime\n\nExclusion Criteria:\n\n* Prior history of other cancer within 5 years\n* Chemotherapy or radiotherapy of target lesion within 3 weeks prior to inclusion\n* Target therapy within less than 5 \\* half-life of the substance prior to inclusion\n* Major surgery within 15 days prior to inclusion\n* Presence of any NCI-CTCAE v5 grade ≥ 2 cardiac, hepatic, pulmonary or renal toxicity\n* Severe myelosuppression\n* Severe peripheral neuropathy (grade ≥ 2)\n* Fructose intolerance\n* Inflammatory bowel chronic disease and\u002For intestinal obstruction\n* Patients with demyelinating form of Charcot-Marie-Tooth disease\n* Known active viral hepatitis or known human immunodeficiency virus (HIV) infection or any other uncontrolled infection.\n* Known hypersensitivity to dacarbazine (DTIC), isotretinoin or to any of the trial drugs, trial drug classes, excipients in the formulation\n* Hyperlipidemia and hypervitaminosis A\n* Vaccination with a live attenuated vaccine within 1 month prior to inclusion\n* Pregnant or breastfeeding patients\n* Inability to comply with medical follow-up of the trial (geographical, social or psychological reasons)","ALL","18 Months","17 Years",{"count":348,"type":349},28,"ESTIMATED","INTERVENTIONAL",[352,353],"PHASE1","PHASE2","This is a multicenter, interventional, non-randomized study among patients with a relapsed or refractory Wilms tumor. The study will aim to assess efficacy of metronomic chemotherapy, in terms of disease control after two cycles of metronomic chemotherapy.",[356],"Wilms Tumor",[358,359,356,360],"Multidrug chemotherapy","metronomic chemotherapy","Renal cancer","2026-03-16",{"date":363,"type":364},"2026-03-18","ACTUAL",{"date":366,"type":364},"2022-09-14",{"date":368,"type":349},"2028-10",{"name":5,"class":6},18]